DK0680517T3 - Fremgangsmåde og diagnostiske sæt til bestemmelseaf en forbindelses toksicitet under anvendelse afstress-promotorer fra pat - Google Patents

Fremgangsmåde og diagnostiske sæt til bestemmelseaf en forbindelses toksicitet under anvendelse afstress-promotorer fra pat

Info

Publication number
DK0680517T3
DK0680517T3 DK94907826T DK94907826T DK0680517T3 DK 0680517 T3 DK0680517 T3 DK 0680517T3 DK 94907826 T DK94907826 T DK 94907826T DK 94907826 T DK94907826 T DK 94907826T DK 0680517 T3 DK0680517 T3 DK 0680517T3
Authority
DK
Denmark
Prior art keywords
stress
methods
diagnostic kits
toxic
compound
Prior art date
Application number
DK94907826T
Other languages
English (en)
Other versions
DK0680517T4 (da
Inventor
Spencer B Farr
Marque D Todd
Original Assignee
Harvard College
Xenometrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21734317&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0680517(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College, Xenometrix Inc filed Critical Harvard College
Application granted granted Critical
Publication of DK0680517T3 publication Critical patent/DK0680517T3/da
Publication of DK0680517T4 publication Critical patent/DK0680517T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94907826T 1993-01-21 1994-01-21 Fremgangsmåde og diagnostiske sæt til bestemmelse af en forbindelses toksicitet under anvendelse afstress-promotorer fra pattedyr DK0680517T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US889693A 1993-01-21 1993-01-21
PCT/US1994/000583 WO1994017208A1 (en) 1993-01-21 1994-01-21 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound

Publications (2)

Publication Number Publication Date
DK0680517T3 true DK0680517T3 (da) 1998-07-27
DK0680517T4 DK0680517T4 (da) 2005-05-02

Family

ID=21734317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94907826T DK0680517T4 (da) 1993-01-21 1994-01-21 Fremgangsmåde og diagnostiske sæt til bestemmelse af en forbindelses toksicitet under anvendelse afstress-promotorer fra pattedyr

Country Status (12)

Country Link
US (3) US5811231A (da)
EP (1) EP0680517B2 (da)
JP (1) JP3509100B2 (da)
AT (1) ATE160178T1 (da)
AU (1) AU692434B2 (da)
CA (1) CA2154265C (da)
DE (1) DE69406772T3 (da)
DK (1) DK0680517T4 (da)
ES (1) ES2111289T5 (da)
GR (1) GR3026129T3 (da)
HK (1) HK1004920A1 (da)
WO (1) WO1994017208A1 (da)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017208A1 (en) * 1993-01-21 1994-08-04 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
JP3810791B2 (ja) * 1993-09-10 2006-08-16 ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク 緑色蛍光タンパク質の使用
GB9420735D0 (en) * 1994-10-14 1994-11-30 Karobio Ab Reporter cell line
GB9424497D0 (en) * 1994-12-05 1995-01-25 Karobio Ab Reporter cell line
US6387651B1 (en) 1995-04-12 2002-05-14 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a microwell device
US6326140B1 (en) 1995-08-09 2001-12-04 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5777888A (en) * 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
GB9526509D0 (en) * 1995-12-23 1996-02-28 Univ Dundee Gene control
US6110671A (en) * 1996-04-04 2000-08-29 The United States Of America As Represented By The Secretary Of The Army Method of measuring tumor suppressor gene p53
US5928888A (en) * 1996-09-26 1999-07-27 Aurora Biosciences Corporation Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
EP0972074A1 (en) * 1997-02-28 2000-01-19 E.I. Du Pont De Nemours & Company Incorporated A method for identifying the site of action of xenobiotic chemicals
GB9706414D0 (en) * 1997-03-27 1997-05-14 Univ Manchester Detection of DNA damage
US7031843B1 (en) * 1997-09-23 2006-04-18 Gene Logic Inc. Computer methods and systems for displaying information relating to gene expression data
EP0969100A4 (en) * 1997-09-29 2005-03-16 Hsp Res Inst Inc METHOD FOR THE INVESTIGATION OF EXPRESSION-INDUCTIVE REGULATORS OF HEAT SHOCK PROTEINS
AU1166199A (en) * 1997-11-20 1999-06-15 Smithkline Beecham Corporation Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
AU2895099A (en) * 1998-03-06 1999-09-20 E.I. Du Pont De Nemours And Company Methods for identifying polycationic, peptide-like compounds with antibacterial activity
US5965352A (en) 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
KR20010052341A (ko) * 1998-05-12 2001-06-25 로제타 인파마틱스 인코포레이티드 유전자 발현 분석을 위한 정량 방법, 시스템, 장치
US6132969A (en) * 1998-06-19 2000-10-17 Rosetta Inpharmatics, Inc. Methods for testing biological network models
US6501003B1 (en) * 1998-07-08 2002-12-31 Wisconsin Alumni Research Foundation Transgentic mouse expressing green fluorescent protein in glial cells
US20030105044A1 (en) * 2001-10-17 2003-06-05 Isis Pharmaceuticals Inc. Antisense modulation of matrix metalloproteinase 1 expression
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
US6468476B1 (en) 1998-10-27 2002-10-22 Rosetta Inpharmatics, Inc. Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
US6203987B1 (en) 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
US6950752B1 (en) 1998-10-27 2005-09-27 Rosetta Inpharmatics Llc Methods for removing artifact from biological profiles
US6453241B1 (en) 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6222093B1 (en) * 1998-12-28 2001-04-24 Rosetta Inpharmatics, Inc. Methods for determining therapeutic index from gene expression profiles
US6370478B1 (en) 1998-12-28 2002-04-09 Rosetta Inpharmatics, Inc. Methods for drug interaction prediction using biological response profiles
AU4186600A (en) * 1999-03-31 2000-10-16 Rosetta Inpharmatics, Inc. Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs
ATE340267T1 (de) 1999-04-14 2006-10-15 Sumitomo Chemical Co Zelle zur bestimmung der fähigkeit die aktivität eines liganden-abhängigen transkriptionskontrollfaktors zu kontrollieren
CA2370749A1 (en) 1999-04-20 2000-10-26 Target Discovery, Inc. Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database
US6673554B1 (en) * 1999-06-14 2004-01-06 Trellie Bioinformatics, Inc. Protein localization assays for toxicity and antidotes thereto
WO2001000791A1 (en) * 1999-06-28 2001-01-04 University Of Southern California Stress-responsive induction of a therapeutic agent and methods of use
US7049132B1 (en) * 1999-06-28 2006-05-23 University Of Southern California Stress-responsive induction of a therapeutic agent and methods of use
US6692916B2 (en) * 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US20080183395A1 (en) * 1999-06-28 2008-07-31 Michael Bevilacqua Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
US20050060101A1 (en) * 1999-06-28 2005-03-17 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US20040225449A1 (en) * 1999-06-28 2004-11-11 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
US20060115826A1 (en) * 1999-06-28 2006-06-01 Michael Bevilacqua Gene expression profiling for identification monitoring and treatment of multiple sclerosis
US6960439B2 (en) * 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US6931396B1 (en) 1999-06-29 2005-08-16 Gene Logic Inc. Biological data processing
US20020087511A1 (en) * 1999-09-02 2002-07-04 Johnson Peter C. Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population
US6727100B1 (en) * 1999-10-21 2004-04-27 4Sc Ag Method of identifying candidate molecules
GB2355791B (en) * 1999-10-28 2004-10-20 Molecular Light Tech Res Ltd Detection of mRNA expression using chemiluminescent labelled probes
EP1130086A1 (en) * 2000-02-18 2001-09-05 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Genetically engineered keratinocytes and toxicity assay using said keratinocytes
US20040115627A1 (en) * 2000-04-12 2004-06-17 Judy Raucy Compositions and methods for induction of proteins involved in xenobiotic metabolism
US6696239B1 (en) 2000-04-20 2004-02-24 Biolog, Inc. Comparative phenotype analysis for assessment of biological active compounds such as antimicrobials
US6828097B1 (en) * 2000-05-16 2004-12-07 The Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
IL152727A0 (en) * 2000-05-16 2003-06-24 Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
US6902882B2 (en) 2000-05-23 2005-06-07 Kerong Gu Methods of monitoring production of gene products and uses thereof
US7020561B1 (en) 2000-05-23 2006-03-28 Gene Logic, Inc. Methods and systems for efficient comparison, identification, processing, and importing of gene expression data
US20030171876A1 (en) * 2002-03-05 2003-09-11 Victor Markowitz System and method for managing gene expression data
JP2004503256A (ja) * 2000-06-14 2004-02-05 ビスタジェン　インコーポレイテッド 肝臓幹細胞を使用する毒性分類
CA2415328A1 (en) * 2000-07-19 2002-01-24 Pointilliste, Inc. Nested sorting and high throughput screening
EP1409718A2 (en) * 2000-07-21 2004-04-21 Phase-1 Molecular Toxicology Canine toxicity genes
US7613571B2 (en) * 2000-07-28 2009-11-03 Doyle Michael D Method and system for the multidimensional morphological reconstruction of genome expression activity
EP1364049A2 (en) * 2000-07-31 2003-11-26 Gene Logic, Inc. Molecular toxicology modeling
US7590493B2 (en) * 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
CA2327581A1 (en) * 2000-12-27 2002-06-27 Yves Blais Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules
AU2002237879A1 (en) * 2001-01-23 2002-08-06 Gene Logic, Inc. A method and system for predicting the biological activity, including toxicology and toxicity, of substances
CA2437498A1 (en) * 2001-02-05 2002-08-15 Shen Quan Pan Methods and kits for identifying scavengers of reactive oxygen species (ros)
EP1434988A4 (en) * 2001-02-23 2005-12-14 Elan Pharm Inc TRANSGENIC ANIMALS KNOCKOUT WITH GENE BACE-1 INACTIVE
WO2002073504A1 (en) * 2001-03-14 2002-09-19 Gene Logic, Inc. A system and method for retrieving and using gene expression data from multiple sources
US20020159625A1 (en) * 2001-04-02 2002-10-31 Cytoprint, Inc. Method and apparatus for discovering, identifying and comparing biological activity mechanisms
CA2447357A1 (en) * 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
US7447594B2 (en) * 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
CA2452897A1 (en) * 2001-07-10 2003-08-21 Gene Logic, Inc. Cardiotoxin molecular toxicology modeling
US20070054269A1 (en) * 2001-07-10 2007-03-08 Mendrick Donna L Molecular cardiotoxicology modeling
US20030143612A1 (en) * 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
US7251642B1 (en) 2001-08-06 2007-07-31 Gene Logic Inc. Analysis engine and work space manager for use with gene expression data
WO2003016500A2 (en) * 2001-08-16 2003-02-27 Phase-1 Molecular Toxicology, Inc. Human toxicologically relevant genes and arrays
WO2003018839A1 (en) * 2001-08-23 2003-03-06 University College Dublin, National University Of Ireland, Dublin Identification of a common promoter module in disease associated genes
JP2003079365A (ja) 2001-09-07 2003-03-18 Kanegafuchi Chem Ind Co Ltd 環境有害化学物質の高感度検出法
US7842498B2 (en) 2001-11-08 2010-11-30 Bio-Rad Laboratories, Inc. Hydrophobic surface chip
JP5236856B2 (ja) 2001-11-09 2013-07-17 ライフ テクノロジーズ コーポレーション 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定
CA2472030A1 (en) * 2002-01-24 2003-07-31 Pointilliste, Inc. Use of collections of binding sites for sample profiling and other applications
ATE426020T1 (de) 2002-01-31 2009-04-15 Univ Rochester Lichtaktivierte gentransduktion unter verwendung von ultraviolettem licht zur zellengerichteten zufuhrung von genen
EP1476747A4 (en) * 2002-01-31 2008-06-11 Ocimum Biosolutions Inc MOLECULAR HEPATOTOXICOLOGICAL MODELING
US7704272B2 (en) 2002-01-31 2010-04-27 University Of Rochester Method for introducing an ultraviolet light activated viral vector into the spinal column
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
CA2486105A1 (en) * 2002-05-17 2004-04-29 Baylor College Of Medicine Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance
ITTO20020729A1 (it) * 2002-08-14 2004-02-15 Consorzio Interuniversitario Per Le Biotecnologie Cellule di mammifero non umano geneticamente modificate, procedimento per la loro produzione e utilizzo in test di tossicita'.
AU2003287384A1 (en) * 2002-10-30 2004-06-07 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
EP1597577A4 (en) * 2003-02-10 2007-02-21 Pointilliste Inc SELF-ARRANGING ARRAYS AND ITS APPLICATION
US7853406B2 (en) 2003-06-13 2010-12-14 Entelos, Inc. Predictive toxicology for biological systems
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
JP2007501617A (ja) * 2003-08-07 2007-02-01 ジーン ロジック インコーポレイテッド 初代ラット肝細胞毒性モデリング
WO2005045426A2 (en) * 2003-11-10 2005-05-19 Aic Gene expression profiling of hazardous compounds and corresponding database clustering algorithm
US20080281526A1 (en) * 2004-03-22 2008-11-13 Diggans James C Methods For Molecular Toxicology Modeling
EP1751303A2 (en) * 2004-04-07 2007-02-14 Gene Logic, Inc. Hepatotoxicity molecular models
GB0410105D0 (en) * 2004-05-06 2004-06-09 Amersham Biosciences Uk Ltd Method for characterising compounds
US7232808B2 (en) * 2004-08-02 2007-06-19 University Of Iowa Research Foundation Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD)
US7646450B2 (en) * 2005-12-29 2010-01-12 Lg Display Co., Ltd. Light emitting diode array, method of manufacturing the same, backlight assembly having the same, and LCD having the same
WO2007092938A2 (en) * 2006-02-08 2007-08-16 Invitrogen Corporation Cellular assays for signaling receptors
AU2007305166A1 (en) * 2006-10-03 2008-04-10 University Of Southern California GRP78 as a predictor of responsiveness to therapeutic agents
NZ584848A (en) * 2007-09-28 2012-09-28 Intrexon Corp Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
KR101629071B1 (ko) 2008-10-08 2016-06-09 인트렉손 코포레이션 다수의 면역조절자를 발현하는 조작된 세포 및 그 용도
EP2199794A1 (en) 2008-12-17 2010-06-23 Universiteit Maastricht Method for the identification of carcinogenic compounds
JP5954883B2 (ja) * 2011-04-08 2016-07-20 アンセム・バイオサイエンシズ・プライベート・リミテッド 真核生物細胞での遺伝毒性物質のハイスループットスクリーニングのためのｉｎｖｉｔｒｏ方法
US11702707B2 (en) * 2011-09-08 2023-07-18 Attagene, Inc. Systems and methods for assessing contamination of drinking water
WO2019070704A1 (en) * 2017-10-02 2019-04-11 Georgia Tech Research Corporation METHODS AND COMPOSITIONS FOR ENGINEERING SYNTHESIS BIOLOGICAL SWITCHES FOR REMOTE CONTROL OF BIOLOGICAL ACTIVITY
CN112040839A (zh) 2018-02-09 2020-12-04 W.L.戈尔及同仁股份有限公司 可植入进入室及相关联的使用方法
KR102382748B1 (ko) * 2020-07-28 2022-04-05 가톨릭대학교 산학협력단 Egr1 프로모터 영역을 포함하는 재조합 벡터 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533584B1 (fr) * 1982-09-28 1986-03-21 Pasteur Institut Procede de detection du pouvoir mutagene de substances, susceptibles d'induire la deterioration d'adn cellulaires, mettant en jeu la production d'une reponse sos
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US4997757A (en) * 1987-12-23 1991-03-05 Genebiomed, Inc. Process for detecting potential carcinogens
NL8801826A (nl) * 1988-07-19 1990-02-16 Tno Werkwijze voor het detecteren van mutaties in markergenen.
US5232833A (en) * 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
GB8905394D0 (en) * 1989-03-09 1989-04-19 Delta Biotechnology Ltd Detection of certain molecules
US5149634A (en) * 1989-04-14 1992-09-22 The University Of Maryland Bioassay for environmental quality
KR920703785A (ko) † 1989-07-18 1992-12-18 존 알. 스텝헨손 자동화 실험장치
ATE238431T1 (de) † 1989-07-18 2003-05-15 Osi Pharm Inc Methode der veränderung der expression von genen bei der transkription und zum nachweis von chemischen substanzen, die wie modulatoren der genexpression wirken
US5665543A (en) * 1989-07-18 1997-09-09 Oncogene Science, Inc. Method of discovering chemicals capable of functioning as gene expression modulators
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
KR930703462A (ko) * 1990-09-24 1993-11-30 로저 브렌트 검색 분석 방법
DE69132031T2 (de) * 1990-12-20 2000-07-13 Arch Development Corp., The University Of Chicago Kontrolle der genexpression durch ionisierende strahlung
NL9100567A (nl) * 1991-04-02 1992-11-02 Ingeny Bv Werkwijze voor het detecteren van mutaties, transgeen zoogdier, transgene zoogdiercel, en werkwijze voor het onderzoeken van stoffen of omstandigheden op mutagene eigenschappen.
CA2070058A1 (en) * 1991-05-31 1992-12-01 Robert A. Gadski Vectors and methods for assaying the regulation of apolipoprotein ai synthesis
KR100300932B1 (ko) * 1992-07-06 2001-10-22 조이스 브린톤 리포터유전자에융합된세균의스트레스프로모터를이용하여독성을측정하는방법및진단키트
WO1994017208A1 (en) * 1993-01-21 1994-08-04 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound

Also Published As

Publication number Publication date
AU692434B2 (en) 1998-06-11
WO1994017208A1 (en) 1994-08-04
JP3509100B2 (ja) 2004-03-22
EP0680517B1 (en) 1997-11-12
CA2154265C (en) 2011-01-04
DK0680517T4 (da) 2005-05-02
US5811231A (en) 1998-09-22
ATE160178T1 (de) 1997-11-15
DE69406772D1 (de) 1997-12-18
HK1004920A1 (en) 1998-12-11
JPH09503121A (ja) 1997-03-31
ES2111289T3 (es) 1998-03-01
US20030027127A1 (en) 2003-02-06
ES2111289T5 (es) 2005-07-16
GR3026129T3 (en) 1998-05-29
EP0680517A1 (en) 1995-11-08
CA2154265A1 (en) 1994-08-04
US20030219714A1 (en) 2003-11-27
DE69406772T3 (de) 2005-11-17
EP0680517B2 (en) 2005-01-19
DE69406772T2 (de) 1998-03-12
AU6124394A (en) 1994-08-15

Similar Documents

Publication Publication Date Title
DK0680517T3 (da) Fremgangsmåde og diagnostiske sæt til bestemmelseaf en forbindelses toksicitet under anvendelse afstress-promotorer fra pat
SG77101A1 (en) Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
EA200000325A1 (ru) Способ доставки генов в антиген-презентирующие клетки кожи
FI925986A0 (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
EA200500120A1 (ru) Рекомбинантные тканезащитные цитокины и кодирующие их нуклеиновые кислоты для защиты, восстановления и усиления чувствительных клеток, тканей и органов
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
ATE266723T1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
BRPI0315666B8 (pt) dna de a34 e a33 do tipo 3, proteínas, seus anticorpos e métodos de tratamento usando os mesmos
BR0303011A (pt) Painel de diagnóstico de câncer
DK0406029T3 (da) Stressproteiner fra svampe
ATE413881T1 (de) Verfahren und zubereitungen um resistenz gegen biologische oder chemische therapien zu überwinden
DE69322166D1 (de) Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon
DE69735436D1 (de) Methode zum nachweis von zell-apoptose
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
ATE347606T1 (de) Gentherapie für kongestives herzversagen
SE0301987D0 (sv) New polypeptide
EA199800352A1 (ru) ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА
Audebert et al. The carboxy‐terminal sequence Asp427–Glu432 of β‐tubulin plays an important function in axonemal motility
DE69837808D1 (de) pRb2/p130 PEPTIDINHIBITOREN DER cdk2 KINASEAKTIVITÄT
IT1283899B1 (it) Peptidi e loro usi nella terapia della malattia celiaca
TR200200097T2 (tr) Yeni antimikotikler, fungizidler, bunların üretimine ilişkin metotlar.
Lynch Aftermaths of Brain Lesions: Plasticity and Recovery of Function in the Central Nervous System. Proceedings of a conference, Worcester, Mass., Sept. 1973. Donald G. Stein, Jeffrey J. Rosen, and Nelson Butters, Eds. Academic Press, New York, 1974. xii, 516 pp., illus. $19.50.